Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 41,764 | N/A | N/A |
| TOTAL | $42,379 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 1,640 | N/A | N/A |
| Other Non-Current Assets | 5,364 | 0 | 0 |
| TOTAL | $7,004 | $N/A | $N/A |
| Total Assets | $49,383 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,010 | 0 | 0 |
| Accrued Expenses | 943 | N/A | N/A |
| TOTAL | $2,396 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 64,125 | 0 | 0 |
| TOTAL | $64,125 | $N/A | $N/A |
| Total Liabilities | $66,521 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -17,406 | N/A | N/A |
| TOTAL | $-17,138 | $N/A | $N/A |
| Total Liabilities And Equity | $49,383 | $0 | $0 |